California State Teachers Retirement System (CalSTRS)’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RLMD
DTC
RI
PCM
PAI
California State Teachers Retirement System (CalSTRS)'s RLMD Position: Q2 2023 in Review
California State Teachers Retirement System (CalSTRS) sold out of Relmada Therapeutics (RLMD) in Q2 2023, closing a stake of 10,183 shares — an estimated $23K sold.
California State Teachers Retirement System (CalSTRS) first reported a position in RLMD in Q2 2020 and held it in 12 quarters. The position peaked at $1.12M in Q3 2022. 95 funds tracked by Wall St. Rank hold RLMD as of Q2 2023.
- California State Teachers Retirement System (CalSTRS) reported no remaining Relmada Therapeutics position as of Q2 2023 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 10,183 Relmada Therapeutics shares in Q2 2023, an estimated $23K.
- California State Teachers Retirement System (CalSTRS) first reported a position in Relmada Therapeutics in Q2 2020 and held it in 12 quarters.
- California State Teachers Retirement System (CalSTRS)'s Relmada Therapeutics position peaked at $1.12M in Q3 2022.
- 95 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2023.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2023, filed 21 Aug 2023.